Research Topic

Osteoporosis in Rheumatic Diseases, What's New?

About this Research Topic

Osteoporosis (OP) is a progressive systemic disease, characterized by low bone mass and micro-architecture deterioration of the bone tissue, with a consequent increase in bone fragility and fracture risk. Treatment of this disease often necessitates a multidisciplinary approach. OP may be classified as either primary or secondary. Primary OP is bone loss associated with the aging process in both men and women. Although the rate of activation of skeletal bone remodelling units in primary OP is normal, the filling of bone resorption pits is incomplete. Secondary OP is bone loss due to a variety of chronic medical conditions, such as medication effects or nutritional deficiencies. Most types of secondary OP show an increase in the activation rate of skeletal bone remodelling units, at least initially, to such an extent that an increased proportion of the skeleton undergoes remodelling at any given time.

Several studies have demonstrated that patients with rheumatic inflammatory diseases have an increased risk of low bone mass. In rheumatic diseases such as SSc and RA, the aetiology of bone loss is multifactorial and may be due to disability, age, longstanding diseases, low body mass index (BMI), chronic systemic inflammation and/or low vitamin D serum concentrations. Few studies have evaluated the role of new techniques e.g. trabecular bone score (TBS) and ultrasound, for the screening of OP.

The goal of this Research Topic is to make a summary of the situation based on our knowledge of osteoporosis in rheumatic diseases, paying particular attention to new discoveries on the use of innovative technologies, such as TBS or ultrasound.

Although we are interested in all types of manuscripts, we are particularly interested in case reports, literature reviews and brief and/or extended reports. All material must cover osteoporosis in rheumatic diseases studied and documented by laboratory and radiological assessments.


Keywords: osteoporosis, rheumatic diseases, bone mineral density (BMD), fragility fracture, trabecular bone score (TBS)


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Osteoporosis (OP) is a progressive systemic disease, characterized by low bone mass and micro-architecture deterioration of the bone tissue, with a consequent increase in bone fragility and fracture risk. Treatment of this disease often necessitates a multidisciplinary approach. OP may be classified as either primary or secondary. Primary OP is bone loss associated with the aging process in both men and women. Although the rate of activation of skeletal bone remodelling units in primary OP is normal, the filling of bone resorption pits is incomplete. Secondary OP is bone loss due to a variety of chronic medical conditions, such as medication effects or nutritional deficiencies. Most types of secondary OP show an increase in the activation rate of skeletal bone remodelling units, at least initially, to such an extent that an increased proportion of the skeleton undergoes remodelling at any given time.

Several studies have demonstrated that patients with rheumatic inflammatory diseases have an increased risk of low bone mass. In rheumatic diseases such as SSc and RA, the aetiology of bone loss is multifactorial and may be due to disability, age, longstanding diseases, low body mass index (BMI), chronic systemic inflammation and/or low vitamin D serum concentrations. Few studies have evaluated the role of new techniques e.g. trabecular bone score (TBS) and ultrasound, for the screening of OP.

The goal of this Research Topic is to make a summary of the situation based on our knowledge of osteoporosis in rheumatic diseases, paying particular attention to new discoveries on the use of innovative technologies, such as TBS or ultrasound.

Although we are interested in all types of manuscripts, we are particularly interested in case reports, literature reviews and brief and/or extended reports. All material must cover osteoporosis in rheumatic diseases studied and documented by laboratory and radiological assessments.


Keywords: osteoporosis, rheumatic diseases, bone mineral density (BMD), fragility fracture, trabecular bone score (TBS)


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

31 July 2020 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

31 July 2020 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..